2 May

Ozempic’s patent expired 4 weeks ago. 50 factories in India were waiting. Australia’s drug regulators are heavily influenced by Big Pharma. But the wonder drugs at cheaper prices are starting to arrive. And Ozempic is now relatively old-hat (though still good). The newer Gliptins are much better again. And research is happening at lightning speed. Lots of competitors means downwards pressure on prices.